What is RespiQ?
RespiQ is a health technology company founded in 2019 by experienced professionals dedicated to empowering individuals to manage their wellbeing. The company is developing advanced technology focused on the early detection of health issues, offering accurate and cost-effective at-home health testing solutions. RespiQ's mission is to provide accessible tools for proactive health management, leveraging innovation to improve health outcomes.
How much funding has RespiQ raised?
RespiQ has raised a total of $4.3M across 1 funding round:
Grant
$4.3M
Grant (2023): $4.4M with participation from The European Innovation Council
Key Investors in RespiQ
The European Innovation Council
The European Innovation Council is an entity operating within the Colleges & Universities sector, known for supporting innovation and technological advancement.
What's next for RespiQ?
The recent major strategic investment signifies a pivotal moment for RespiQ, likely enabling the company to accelerate its product development, scale its operations, and expand its market reach. This capital infusion is expected to fuel further innovation in early health detection technology and solidify RespiQ's position as a key player in the preventative health market. The company is poised to enhance its offerings and potentially explore new diagnostic capabilities.
See full RespiQ company page
